> Procedures > Diagnostic Procedure > Coronary Angiography

Coronary Angiography

Q: What are the different types of coronary angiography procedures?

Coronary angiography can be performed using a few different techniques: 1. Conventional coronary angiography: This is the standard approach where a thin, flexible tube (catheter) is inserted into an artery, usually in the groin or arm, and threaded up to the heart. A contrast dye is then injected and X-ray images are taken. 2. Computed tomography (CT) coronary angiography: This non-invasive technique uses a CT scanner to create detailed, 3D images of the coronary arteries. It does not require inserting a catheter. 3. Optical coherence tomography (OCT) coronary angiography: This imaging method uses near-infrared light to produce high-resolution, cross-sectional images of the coronary arteries. It provides more detailed information compared to conventional angiography. The type of coronary angiography used depends on the individual patient's needs and the preferences of the medical team.

Q: What are some common challenges or limitations with coronary angiography?

While coronary angiography is generally safe, there are a few potential challenges and limitations to be aware of: 1. Radiation exposure: The X-ray imaging used during conventional coronary angiography exposes patients to small amounts of radiation. This risk needs to be weighed against the benefits of the procedure. 2. Contrast dye reactions: Some patients may have allergic reactions or other side effects to the contrast dye used. Doctors closely monitor for these reactions. 3. Artery damage: There is a small risk of damaging the artery during catheter insertion or dye injection. Experienced cardiologists help minimize this risk. 4. Incomplete visualization: Coronary angiography can sometimes miss or underestimate the severity of certain types of artery blockages, particularly in smaller vessels. Addressing these limitations is an active area of research, and PubCompare.ai can help streamline this process by easily locating the latest and most effective coronary angiography protocols from the literature.

Q: How can PubCompare.ai assist with coronary angiography research?

PubCompare.ai's AI-powered protocol optimization can greatly benefit coronary angiography research in several ways: 1. Efficient literature screening: PubCompare.ai allows you to quickly and efficiently screen the vast amount of published literature, pre-prints, and patents related to coronary angiography protocols. This saves valuable time in the research process. 2. Identification of critical insights: The platform's AI-driven analysis can help pinpoint key differences in protocol effectiveness, enabling you to identify the most optimal approaches for your specific research goals and improve reproducibility. 3. Streamlined comparison: By leveraging intelligent comparisons, PubCompare.ai makes it easy to evaluate the relative merits of different coronary angiography protocols from multiple sources. This supports more informed decision-making. 4. Accuracy and reproducibility: Choosing the best protocols from the literature, as facilitated by PubCompare.ai, can lead to improved accuracy and reproducibility in your coronary angiography research - critical factors in this field of cardiovascullar medicine. Ultimately, PubCompare.ai's cutting-edge technology can help you navigate the complexities of coronary angiography research more efficiently and effectively.

Q: What are some of the key applications of coronary angiography?

Coronary angiography is an important diagnostic and treatment tool for a wide range of cardiovascular conditions, including: 1. Coronary artery disease: Angiography can identify the location and severity of blockages or narrowing in the coronary arteries, allowing for appropriate treatment planning. 2. Heart attack evaluation: Angiography can quickly determine if a heart attack is caused by a blocked artery, guiding emergency treatment. 3. Heart valve problems: Angiography can assess the function of heart valves and identify any issues that may require surgical intervention. 4. Congenital heart defects: Angiography can provide detailed images of the structure and blood flow in the heart, helping diagnose and manage congenital heart problems. 5. Aortic disease: Angiography can detect issues with the aorta, the main artery that carries blood from the heart to the rest of the body. By leveraging PubCompare.ai's AI-powered protocol optimization, researchers can more easily identify the most effective angiography approaches for these critical applications, ultimately leading to improved patient outcomes.

Coronary angiography is a medical imaging technique used to visualize the inside of coronary arteries, the vessels that supply the heart muscle with blood and oxygen.
This procedure involves injecting a contrast dye into the coronary arteries and taking X-ray images to assess the presence, location, and severity of any blockages or narrowing.
Coronary angiography is an important tool for diagnosing and treatin heart disease, and is often used in conjunction with other cardiovascular imaging modalities.
The descripion outlines how PubCompare.ai's AI-powered protocol optimization can streamline coronary angiography research by easily locating the best protocols from literature, pre-prints, and patents, leading to improved reproducibility and accuracy in this critical field of cardiovsacular medicine.

Most cited protocols related to «Coronary Angiography»

Prospective Study of Stable CAD Patients

MIPS is a prospective study of stable CAD patients enrolled between June 2011 and August 2014 from Emory University affiliated hospitals and clinics, including Emory University Hospital, Grady Memorial Hospital, Emory Midtown Hospital and the Atlanta VA Medical Center. Patients were enrolled if they were 30 to 79 years of age and had documented CAD defined as any of the following: an abnormal coronary angiogram demonstrating evidence of atherosclerosis with at least luminal irregularities, previous percutaneous or surgical coronary revascularization, a history of myocardial infarction (MI), or a positive nuclear stress test. Patients were excluded if they had an acute coronary syndrome or decompensated heart failure in the prior week, severe psychiatric conditions other than major depression, pregnancy (women of childbearing age were screened by pregnancy test), uncontrolled high blood pressure (≥180/110 mmHg), or with contraindications for regadenoson administration. Beta-adrenergic antagonists were held for 24 hours and calcium channel blockers and nitrates for at least 12 hours prior to the stress test. Patients for whom withholding medications was considered unsafe were excluded. The diagnosis of heart failure was made using the following criteria: a) self-reported history of heart failure that was confirmed by chart review; b) medical chart review for previous diagnosis of heart failure (all patients were seen by a cardiologist at Emory affiliated hospitals before enrollment); c) ICD codes and adjudication by research personnel. Coronary angiographic data were collected by chart review with a median time between the angiogram and enrollment of 2.1 (1.0 – 4.4) years. The Emory University Institutional Review Board approved the research protocol, and all participants provided written informed consent.

Hammadah M., Al Mheid I., Wilmot K., Ramadan R., Shah A.J., Sun Y., Pearce B., Garcia E.V., Kutner M., Bremner J.D., Esteves F., Raggi P., Sheps D.S., Vaccarino V, & Quyyumi A.A. (2017). The Mental Stress Ischemia Prognosis Study (MIPS): Objectives, Study Design, and Prevalence of Inducible Ischemia. Psychosomatic medicine, 79(3), 311-317.

Publication 2016

Acute Coronary Syndrome Adrenergic beta-Antagonists Angiography ARID1A protein, human Atherosclerosis Calcium Channel Blockers Cardiologists Congestive Heart Failure Coronary Angiography Diagnosis Disorder, Depressive Ethics Committees, Research Exercise Tests Heart High Blood Pressures Myocardial Infarction Nitrates Operative Surgical Procedures Patients Pharmaceutical Preparations Phenobarbital Pregnancy Pregnancy Tests regadenoson TNPO1 protein, human Vision Woman

Comprehensive Baseline Data Collection for Biobank

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2017

Antihypertensive Agents Blood Glucose Body Weight Cardiovascular Diseases Childbirth Complete Blood Count Coronary Angiography Diagnosis Drug Reaction, Adverse Eating Echocardiography Enzymes Ethanol High Blood Pressures Index, Body Mass Japanese Kidney Lipids Liver Function Tests Malignant Neoplasms Operative Surgical Procedures Pharmaceutical Preparations Pharmacotherapy Pressure, Diastolic Radiotherapy Systole Systolic Pressure Therapeutics Tumor Markers Urinalysis Woman

Comparative Evaluation of Coronary Angiography Scoring Systems

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2012

Angiography Blood Vessel Coronary Angiography Hemodynamics Inclusion Bodies Myocardium Stenosis

Developing Symptom Indicators for IC/PBS

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2010

Acclimatization Coronary Angiography Crohn Disease Diabetes Mellitus, Non-Insulin-Dependent Diagnosis Endometriosis Low Back Pain Patients Spinal Manipulation Therapeutics Vulvodynia

Diagnostic Accuracy of 64-Slice CT Angiography

The “Coronary Evaluation Using Multidetector Spiral Computed Tomography Angiography using 64 Detectors” or “CORE-64” study was designed to evaluate the diagnostic accuracy of multislice spiral CT angiography using 64 detector rows for identifying coronary artery stenosis in patients with suspected or known significant coronary artery disease. The study was designed as a prospective, multi-centre (nine centres), international (seven countries) study examining the diagnostic accuracy of 64-slice CT in comparison with CCA. The primary hypothesis of the study was that 64-slice CT coronary angiography will be able to detect significant coronary artery disease in a patient with acceptable diagnostic accuracy as compared to CCA. Significant CAD is defined as ≥50% stenosis as determined by coronary angiography (QCA) of CCA. The primary diagnostic parameters were per-patient sensitivity and specificity compared with CCA. These were analysed using both point estimates and continuous measurements (using area under the receiver-operating characteristics curve) expressed with 95% confidence intervals for the corresponding true values to indicate the precision of the estimates. We also compared the diagnostic performance of CCA with that of MSCT for anatomy-based prediction of subsequent clinically driven revascularisation on a per-patient and per-vessel level. Other secondary objectives include the evaluation of diagnostic accuracy based on a per-vessel and per-segment unit of analysis, and defining significant stenosis at both ≥50% and ≥70% thresholds, with QCA as the reference standard.

Miller J.M., Dewey M., Vavere A.L., Rochitte C.E., Niinuma H., Arbab-Zadeh A., Paul N., Hoe J., de Roos A., Yoshioka K., Lemos P.A., Bush D.E., Lardo A.C., Texter J., Brinker J., Cox C., Clouse M.E, & Lima J.A. (2008). Coronary CT angiography using 64 detector rows: methods and design of the multi-centre trial CORE-64. European Radiology, 19(4), 816-828.

Publication 2008

Blood Vessel Computed Tomography Angiography Coronary Angiography Coronary Artery Disease Coronary Stenosis Diagnosis Heart Patients Stenosis

Most recents protocols related to «Coronary Angiography»

Invasive LV Pressure and CAD Evaluation

A total of 42 patients, who underwent LV catheterization for coronary angiography, were prospectively included. The invasive LV pressure was recorded. The LV dp/dt min, tau and LVEDP were averaged over 3–6 cardiac cycles. An LVEDP value of > 16 mmHg was defined as an elevated LV filling pressure [23 (link)]. The invasive values were measured by two researchers, who were blinded to the results of the MW measurements. All patients underwent coronary angiography with multiple projections. CAD was defined when the lumen was stenotic for more than 50% in one or more major epicardial coronary arteries [24 (link)].

Guo Y., Wang X., Yang C.G., Meng X.Y., Li Y., Xia C.X., Xu T., Weng S.X., Zhong Y., Zhang R.S, & Wang F. (2023). Noninvasive assessment of myocardial work during left ventricular isovolumic relaxation in patients with diastolic dysfunction. BMC Cardiovascular Disorders, 23, 129.

Publication 2023

Angiography Artery, Coronary Catheterization Catheterizations, Cardiac Coronary Angiography Heart Patients Pressure Stenosis

Angina Pectoris Exercise ECG Screening

In this retrospective study, all patients with angina pectoris and who underwent exercise ECG tests were screened between August 2017 and September 2018. The Institutional Review Board of Mackay Memorial Hospital approved this study protocol (IRB No. 17MMHIS004e), which waived the requirement for informed consent in this retrospective study. The treating physicians decided on the need to perform exercise ECG tests after excluding ECG abnormalities, including LBBB, paced rhythm, Wolff–Parkinson–White syndrome, ≥ 0.1-mV ST-segment depression on resting ECG, or who are being treated with digitalis. The use of exercise ECG test was indicated by treating physicians and re-confirmed by other two cardiologists. Patients with positive exercise ECG were suggested to undergo coronary imaging, including coronary angiography or computed tomography. Based on the coronary stenoses severity, patients with positive exercise ECG were divided into three groups: normal, < 50%, and ≥ 50% stenoses. According to 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes [7 (link)], the negative predictive value of exercise ECG was higher than positive predictive value. The likelihood of CAD was less than 15% if negative exercise ECG. Therefore, patients with negative exercise ECG were defined as a relative health group. Compared with patients with negative exercise ECG, analysis models were designed (model 1, positive exercise ECG; model 2, < 50% and ≥ 50% stenoses; and model 3, normal, < 50%, and ≥ 50% stenoses).

Wang C.L., Wei C.C., Tsai C.T., Lee Y.H., Liu L.Y., Chen K.Y., Lin Y.J, & Lin P.L. (2023). Early detection of myocardial ischemia in resting ECG: analysis by HHT. BioMedical Engineering OnLine, 22, 23.

Publication 2023

Angina Pectoris Cardiologists Congenital Abnormality Coronary Angiography Coronary Stenosis Diagnosis Digitalis Exercise Tests Heart Left Bundle-Branch Block Patients Physicians Stenosis Syndrome Wolff-Parkinson-White Syndrome X-Ray Computed Tomography

Coronary Artery Disease Imaging Protocol

Relevant databases including PubMed, ScienceDirect, and Springer were researched up until July 2019. A total of 803 articles were identified at first research, from which only 18 articles qualified and were included in the final analysis. This outcome was as a result of an extensive evaluations and subsequent rejections due to the following issues: subject to duplication, bias, publication without result, failure by imaging protocol include the aspect of stress, reference standard used not being a coronary angiography, and failure to provide explicit protocol and preparation.

Alenezi M.M., Majrashi N.A., Sharif H., Alyami A.S., Ageeli W.A., Salawi M.H., Refaee T.A, & Alanazi S.F. (2023). A systemic review of rubidium-82 PET contrasted with 99mTc-MIBI SPECT for imaging coronary artery disease. Medicine, 102(10), e33068.

Publication 2023

Coronary Angiography

Systematic Review of Cardiac Imaging Modalities

To achieve the study aim, a systematic review of the literature and a meta-analysis of the results for the 2 tracers was conducted via the search tool of University of Aberdeen (Primo). The
search tool included the following bibliographic databases: ProQuest, EMBASE, PubMed/Medline, web of science, ScienceDirect, VLeBooks, Springer, Lippincott Williams & Wilkins Journals, Wiley Online Library, Dawsonera, and BMJ Journals and Oxford Journals. This search included all articles (not timeframe) with full protocol of MPI test; stress examination published on SPECT, PET, and PET/CT in coronary artery disease. The aim of the systemic review was to find every related study corresponding to well-defined scientific criteria. The research was limited to documents submitted to peer-reviewed papers about human subjects to avoid/prevent selective outcome reports and articles published in English. Besides, the search was also limited to articles focusing on CAD rather than vascular or other cardiac diseases, for example, bypass. The search’s keywords included PET/CT OR PET- CT, SPECT/CT OR SPECT-CT, CORONARY ARTERY DISEASE OR CORONARY ARTERY DISEASES OR CAD.
Finally, a more in-depth analysis was carried out on the conferences abstracts to obtain all relevant data considering that approximately a half of the annually written abstracts are published, hence contributing to the creation of an ascertainment bias.^{[11 (link)]} This study ensured that the last search takes place in June 2019 to allows for the inclusion of up-to-date articles in the analysis. Besides, the standard of reference chosen was the coronary angiography (studies in which the stenosis was 50 per cent and with at least fifteen patients). The rationale for choosing a stenosis of 50% is that the approach is increasingly becoming a clinical routine. In this article, the analytical value was based on sensitivity and specificity terms for SPECT, PET, and PET/CT.
The exclusion criteria adopted included review-articles, phantom cases, preclinical cases, case study reports, articles without the percentage (%) of stenosis being mentioned and lastly articles.
focusing on patients diagnosed with other cardiac diseases, for example, bypass grafts. The other key consideration was the differences in doses administered to patients in each case of SPECT and PET, which was conjectured as an element that would make it difficult to identify the difference in the 2 methods because it is difficult to prove.

Publication 2023

Blood Vessel cDNA Library Conferences Coronary Angiography Coronary Artery Disease Grafts Heart Diseases Homo sapiens Patients Scan, CT PET Single Photon Emission Computed Tomography Computed Tomography Stenosis Tomography, Emission-Computed, Single-Photon

Defining Obstructive Coronary Artery Disease in ATTR-CM

All patients included underwent review of medical records for evidence of oeCAD by two study investigators (R.H., N.M.F.), including symptom history, cardiovascular risk factors, healthcare encounters such as ambulatory clinic visits, Emergency Department visits and hospitalizations, and cardiac investigation findings such as electrocardiogram (ECG), cardiac biomarker (troponin and N-terminal pro-B-type natriuretic peptide, NTproBNP), ECG stress test, stress imaging, coronary computed tomography angiography (CCTA), invasive coronary angiography, history of acute coronary syndrome (ACS) or myocardial infarction (MI), and/or coronary artery revascularization. The clinical indication for oeCAD evaluation, in addition to the temporal relation with ATTR-CM diagnosis (occurring before, after, or simultaneous with) was also collected.
As patients with ATTR-CM often have clinical characteristics and/or non-invasive investigation result findings that resemble oeCAD (such as chest pain, chronically elevated troponin levels, and anterior Q-waves on ECG), a strict definition of oeCAD was used for this analysis. A diagnosis of CAD required ≥ 1 of the following criteria: (1) prior history of coronary artery revascularization by either percutaneous coronary intervention (PCI) and/or coronary artery bypass grafting (CABG), (2) obstructive epicardial coronary artery stenosis of ≥ 70% by CCTA or invasive coronary angiography, or ≥ 50% of the left main coronary artery [11 (link)]. This strict criteria was selected in order to definitively confirm the presence of obstructive epicardial coronary artery disease lesions in ATTR-CM patients, and to discriminate the presence oeCAD from patients who may have microvascular coronary artery disease or findings on non-invasive evaluation (such as ECG or echocardiography) that are secondary to myocardial amyloid fibril infiltration but resemble oeCAD. Among patients with a prior history of ACS/MI, all had subsequent confirmatory invasive coronary angiography.

Hassan R., Miller R.J., Howlett J.G., White J.A, & Fine N.M. (2023). Prevalence, incidence and clinical outcomes of epicardial coronary artery disease among transthyretin amyloidosis cardiomyopathy patients. BMC Cardiovascular Disorders, 23, 124.

Publication 2023

Acute Coronary Syndrome Amyloid Fibrils Artery, Coronary Biological Markers Chest Pain Clinic Visits Computed Tomography Angiography Coronary Angiography Coronary Artery Disease Coronary Stenosis Diagnosis Echocardiography Electrocardiography Exercise Tests Heart Hospitalization Myocardial Infarction Myocardium Patients Percutaneous Coronary Intervention pro-brain natriuretic peptide (1-76) Troponin TTR protein, human

Top products related to «Coronary Angiography»

Axiom artis by Siemens

Sourced in Germany

The Axiom Artis is a medical imaging system designed for diagnostic procedures. It provides high-quality images to support clinical decision-making. The core function of the Axiom Artis is to capture detailed medical images for diagnostic purposes.

Somatom definition flash by Siemens

Sourced in Germany, United States, Japan, Netherlands, United Kingdom

The SOMATOM Definition Flash is a computed tomography (CT) scanner developed by Siemens. It is designed to provide high-quality imaging for a wide range of medical applications. The SOMATOM Definition Flash utilizes advanced technology to capture detailed images of the body, enabling medical professionals to make accurate diagnoses and inform treatment decisions.

Centricity ca 1000 by GE Healthcare

Sourced in United States

The Centricity CA 1000 is a clinical chemistry analyzer designed for in-vitro diagnostic testing. It is capable of performing a variety of clinical chemistry tests on patient samples. The Centricity CA 1000 is intended for use in clinical laboratory settings.

Somatom definition by Siemens

Sourced in Germany, United States, Japan, Netherlands

The Somatom Definition is a computed tomography (CT) scanner developed by Siemens. It is a diagnostic imaging device that uses X-rays to create detailed cross-sectional images of the body.

Allura xper fd20 by Philips

Sourced in Netherlands, Germany

The Allura Xper FD20 is a fluoroscopic imaging system designed for interventional procedures. It features a 20-inch flat-panel detector that provides high-quality, real-time imaging. The system is capable of performing a variety of interventional procedures, including cardiac, vascular, and neuro-interventional procedures.

Pressurewire by Abbott

Sourced in United States, Germany

The PressureWire is a medical device designed to measure intravascular pressure. It provides precise and reliable pressure measurements to support clinical decision-making.

Visipaque by GE Healthcare

Sourced in Ireland, United States, United Kingdom, Germany, Norway, Italy, Denmark

Visipaque is a radiographic contrast agent used in medical imaging procedures. It contains the active ingredient iodixanol, which aids in visualizing internal structures and organs during diagnostic imaging tests.

Vivid 7 by GE Healthcare

Sourced in United States, Norway, United Kingdom, Japan, France, Canada, Germany, Belgium

The Vivid 7 is a high-performance ultrasound system designed for cardiovascular and general imaging applications. It features advanced imaging technologies and versatile capabilities to support comprehensive diagnostic assessments.

Corevalve by Medtronic

Sourced in United States, Ireland, Switzerland

CoreValve is a medical device designed for the treatment of severe aortic stenosis. It is a prosthetic heart valve that is implanted via a minimally invasive procedure to replace the patient's diseased aortic valve.

Cathcorlx by Siemens

Sourced in Germany

CathCorLX is a lab equipment product from Siemens. It is designed for performing cardiac catheterization procedures. The device provides real-time imaging to support medical professionals during these procedures, but a detailed description of its core function is not available while maintaining an unbiased and factual approach.

What are the different types of coronary angiography procedures?

Coronary angiography can be performed using a few different techniques: 1. Conventional coronary angiography: This is the standard approach where a thin, flexible tube (catheter) is inserted into an artery, usually in the groin or arm, and threaded up to the heart. A contrast dye is then injected and X-ray images are taken. 2. Computed tomography (CT) coronary angiography: This non-invasive technique uses a CT scanner to create detailed, 3D images of the coronary arteries. It does not require inserting a catheter. 3. Optical coherence tomography (OCT) coronary angiography: This imaging method uses near-infrared light to produce high-resolution, cross-sectional images of the coronary arteries. It provides more detailed information compared to conventional angiography. The type of coronary angiography used depends on the individual patient's needs and the preferences of the medical team.

What are some common challenges or limitations with coronary angiography?

While coronary angiography is generally safe, there are a few potential challenges and limitations to be aware of: 1. Radiation exposure: The X-ray imaging used during conventional coronary angiography exposes patients to small amounts of radiation. This risk needs to be weighed against the benefits of the procedure. 2. Contrast dye reactions: Some patients may have allergic reactions or other side effects to the contrast dye used. Doctors closely monitor for these reactions. 3. Artery damage: There is a small risk of damaging the artery during catheter insertion or dye injection. Experienced cardiologists help minimize this risk. 4. Incomplete visualization: Coronary angiography can sometimes miss or underestimate the severity of certain types of artery blockages, particularly in smaller vessels. Addressing these limitations is an active area of research, and PubCompare.ai can help streamline this process by easily locating the latest and most effective coronary angiography protocols from the literature.

How can PubCompare.ai assist with coronary angiography research?

PubCompare.ai's AI-powered protocol optimization can greatly benefit coronary angiography research in several ways: 1. Efficient literature screening: PubCompare.ai allows you to quickly and efficiently screen the vast amount of published literature, pre-prints, and patents related to coronary angiography protocols. This saves valuable time in the research process. 2. Identification of critical insights: The platform's AI-driven analysis can help pinpoint key differences in protocol effectiveness, enabling you to identify the most optimal approaches for your specific research goals and improve reproducibility. 3. Streamlined comparison: By leveraging intelligent comparisons, PubCompare.ai makes it easy to evaluate the relative merits of different coronary angiography protocols from multiple sources. This supports more informed decision-making. 4. Accuracy and reproducibility: Choosing the best protocols from the literature, as facilitated by PubCompare.ai, can lead to improved accuracy and reproducibility in your coronary angiography research - critical factors in this field of cardiovascullar medicine. Ultimately, PubCompare.ai's cutting-edge technology can help you navigate the complexities of coronary angiography research more efficiently and effectively.

What are some of the key applications of coronary angiography?

Coronary angiography is an important diagnostic and treatment tool for a wide range of cardiovascular conditions, including: 1. Coronary artery disease: Angiography can identify the location and severity of blockages or narrowing in the coronary arteries, allowing for appropriate treatment planning. 2. Heart attack evaluation: Angiography can quickly determine if a heart attack is caused by a blocked artery, guiding emergency treatment. 3. Heart valve problems: Angiography can assess the function of heart valves and identify any issues that may require surgical intervention. 4. Congenital heart defects: Angiography can provide detailed images of the structure and blood flow in the heart, helping diagnose and manage congenital heart problems. 5. Aortic disease: Angiography can detect issues with the aorta, the main artery that carries blood from the heart to the rest of the body. By leveraging PubCompare.ai's AI-powered protocol optimization, researchers can more easily identify the most effective angiography approaches for these critical applications, ultimately leading to improved patient outcomes.

More about "Coronary Angiography"

Coronary angiography, also known as cardiac catheterization or heart cath, is a crucial medical imaging technique used to visualize the interior of the coronary arteries.
These vessels are responsible for supplying the heart muscle with essential blood and oxygen.
The procedure involves injecting a contrast dye into the coronary arteries and capturing X-ray images to assess the presence, location, and severity of any blockages or narrowing.
Coronary angiography is an indispensable tool for diagnosing and treating heart disease, often used in conjunction with other cardiovascular imaging modalities like echocardiography, cardiac MRI, and CT angiography.
Devices like the Axiom Artis, SOMATOM Definition Flash, Centricity CA 1000, Somatom Definition, and Allura Xper FD20 are commonly used to perform this procedure, while the PressureWire, Visipaque, and Vivid 7 are utilized for related measurements and imaging.
Innovations in coronary angiography research, such as those enabled by PubCompare.ai's AI-powered protocol optimization, can streamline the process by easily locating the best protocols from literature, pre-prints, and patents.
This can lead to improved reproducibility and accuracy in this critical field of cardiovascular medicine, ultimately benefiting patients with conditions like coronary artery disease, myocardial infarction, and valvular heart disease.
PubCompare.ai's cutting-edge technology can also assist with the development of advanced cardiovascular devices like the CoreValve and CathCorLX.